-
Mashup Score: 0
Recent events can provide digital therapeutics companies with clear lessons for the future.
Source: PharmExecCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.
Source: PharmExecCategories: Latest Headlines, Rare DiseaseTweet-
The AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing https://t.co/4RCZ5T7F1f via @pharmexec
-
-
Mashup Score: 0Embracing the Hybrid Era: Leveraging Answer Engines and Generative AI to Improve the Patient and HCP Experience - 10 month(s) ago
Through the power of large language models and generative AI, pharma and biotech companies are transforming medical information delivery by offering direct, trustworthy, and accurate answers to patients and healthcare providers, significantly reducing time and frustration.
Source: PharmExecCategories: Future of Medicine, Latest HeadlinesTweet-
Embracing the Hybrid Era: Leveraging Answer Engines and Generative AI to Improve the Patient and HCP Experience https://t.co/ubwNz3UfNJ https://t.co/Sp5ng4OK7h
-
-
Mashup Score: 0FDA Eyes Advisory Committee Reform to Enhance Credibility - 11 month(s) ago
Agency hopes to update and improve its advisory committee composition and operations—to help FDA scientists “get the best advice possible.”
Source: PharmExecCategories: Latest Headlines, Rare DiseaseTweet-
FDA Eyes Advisory Committee Reform to Enhance Credibility https://t.co/SPjfEyS6qX via @pharmexec
-
-
Mashup Score: 0Pharma 2023: Digital Health Key Takeaways - 1 year(s) ago
Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.
Source: PharmExecCategories: Future of Medicine, Latest HeadlinesTweet-
Pharma 2023: Digital Health Key Takeaways - Industry insights on how #pharma is faring in tapping new innovations and approaches in #digitalhealth. https://t.co/18GUMMQXac https://t.co/NUioKxWyR9
-
-
Mashup Score: 0Indegene Launches Metaverse Capabilities - 1 year(s) ago
The capabilities will support life sciences organizations with a variety of use cases, including health care provider (HCP) interactions, HCP education, and patient education.
Source: PharmExecCategories: Healthcare Professionals, Latest HeadlinesTweet-
Gen Z and Millennials Turning to Social Media for Health Guidance Instead of HCPs https://t.co/DYEbDkINmJ #healthcare #HCPs #GenZ #Millennials #Pharmaceuticals #lifesciences #ehealth #Metaverse #digitalhealth #HCSM https://t.co/aBDbI6dqqo
-
-
Mashup Score: 0Health Equity Barriers in Oncology Trials - 1 year(s) ago
Overcoming persistent barriers to health equity in oncology trials will require innovation and cooperation.
Source: PharmExecCategories: Hem/Oncs, Latest HeadlinesTweet-
Health Equity Barriers in Oncology Trials | featuring @ElenaRiosMD @Walgreens Chief Clinical Trials Officer Ramita Tandon 💪👩⚕️ https://t.co/v1b2grDReZ via @pharmexec @MassiveBio #WorldCancerDay #Diversity #clinicaltrials #CancerResearch
-
-
Mashup Score: 1MAPay to Create First 100 Million NFTs for Digital Health Records on the Algorand Blockchain - 1 year(s) ago
Built on Algorand, and in partnership with the Government of Maharashtra in India, NFT technology will be used for storing personal health data for the first time.
Source: PharmExecCategories: Healthcare Professionals, Latest HeadlinesTweet-
#India @mapaycorp to Create First 100 Million #NFTs for #DigitalHealth Records on the Algorand #Blockchain https://t.co/My2wa28btR
-
-
Mashup Score: 2AI + Social Media: The Intersection of 2 Contemporary Inventions Takes Physician Engagement to the Next Level - 2 year(s) ago
The two technologies are helping HCPs spread information and collect data in new ways.
Source: PharmExecCategories: General Medicine News, Latest HeadlinesTweet-
When it comes to driving education, awareness, and connectivity with patient communities, our May 2022 Physician Impact Report found that two-thirds of physicians spend 2 hours and 22 minutes on social media platforms a day. Read more here at PharmExec. https://t.co/P7Yy0TlHII
-
-
Mashup Score: 0
Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting. What is being done to smooth the path for pricing and reimbursement?
Source: PharmExecCategories: Latest Headlines, Rare DiseaseTweet-
The Price of Innovation: ‘Paying for a Cure’ Remains Costly Proposition https://t.co/ziHqpooB9o via @pharmexec
-
A Crossroads for the Digital Therapeutics Industry. Now is the Time to Act https://t.co/GfdoLCP3wf https://t.co/oMhqe1qd2X